These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 10234602

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole.
    Feola DJ, Garvy BA, Rapp RP, Thornton AC.
    Pharmacotherapy; 2007 Jul; 27(7):937-47. PubMed ID: 17594199
    [Abstract] [Full Text] [Related]

  • 3. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine.
    Venugopalan V, Thornton AC, Steinke DT, Rapp RP, Romanelli F, Feola DJ.
    Pharmacotherapy; 2009 Apr; 29(4):373-82. PubMed ID: 19323617
    [Abstract] [Full Text] [Related]

  • 4. [Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection].
    Piketty C, Gilqouin J, Kazatchkine M.
    Ann Med Interne (Paris); 1996 Apr; 147(5):327-30. PubMed ID: 9033734
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
    Pyle RC, Butterfield JH, Volcheck GW, Podjasek JC, Rank MA, Li JT, Harish A, Poe KL, Park MA.
    J Allergy Clin Immunol Pract; 2014 Apr; 2(1):52-8. PubMed ID: 24565769
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
    Grim SA, Rapp RP, Martin CA, Evans ME.
    Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trimethoprim-sulfamethoxazole and hypouricemia.
    Chertow GM, Seifter JL, Christiansen CL, O'Donnell WJ.
    Clin Nephrol; 1996 Sep; 46(3):193-8. PubMed ID: 8879855
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.
    Martin JN, Rose DA, Hadley WK, Perdreau-Remington F, Lam PK, Gerberding JL.
    J Infect Dis; 1999 Dec; 180(6):1809-18. PubMed ID: 10558935
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Trimethoprim-sulfamethoxazole (TMP/SMX) potentiates indinavir nephrotoxicity.
    de Araujo M, Seguro AC.
    Antivir Ther; 2002 Sep; 7(3):181-4. PubMed ID: 12487385
    [Abstract] [Full Text] [Related]

  • 18. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis.
    Rungoe C, Malchau EL, Larsen LN, Schroeder H.
    Pediatr Blood Cancer; 2010 Aug; 55(2):304-8. PubMed ID: 20583218
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
    Reilly TP, MacArthur RD, Farrough MJ, Crane LR, Woster PM, Svensson CK.
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1356-64. PubMed ID: 10565861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.